|
1
|
Uraoka T, Saito Y, Matsuda T, et al:
Endoscopic indications for endoscopic mucosal resection of
laterally spreading tumours in the colorectum. Gut. 55:1592–1597.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi T, Nosho K, Yamamoto H, et al:
Flat-type colorectal advanced adenomas (laterally spreading tumors)
have different genetic and epigenetic alterations from
protruded-type advanced adenomas. Mod Pathol. 20:139–147. 2007.
View Article : Google Scholar
|
|
3
|
Hiraoka S, Kato J, Tatsukawa M, et al:
Laterally spreading type of colorectal adenoma exhibits a unique
methylation phenotype and K-ras mutations. Gastroenterology.
131:379–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mukawa K, Fujii S, Takeda J, et al:
Analysis of K-ras mutations and expression of cyclooxygenase-2 and
gastrin protein in laterally spreading tumors. J Gastroenterol
Hepatol. 20:1584–1590. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noro A, Sugai T, Habano W and Nakamura S:
Analysis of Ki-ras and p53 gene mutations in laterally spreading
tumors of the colorectum. Pathol Int. 53:828–836. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kusaka T, Fukui H, Sano Y, Ueda Y, Chiba T
and Fujimori T: Analysis of K-ras codon 12 mutations and p53
overexpression in colorectal nodule-aggregating tumors. J
Gastroenterol Hepatol. 15:1151–1157. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Wang X, Gong W, Mi B, Liu S and
Jiang B: Increased expression of beta-catenin, phosphorylated
glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally
spreading colorectal tumors. J Histochem Cytochem. 57:363–371.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frías C, Morán A, de Juan C, et al:
Telomere function in colorectal cancer. World J Gastrointest Oncol.
1:3–11. 2009.
|
|
9
|
Kim NW, Piatyszek MA, Prowse KR, et al:
Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohnishi T, Watanabe T, Nozawa H, Kitayama
J and Nagawa H: Telomerase activity of blood samples and recurrence
of colorectal cancer. Hepatogastroenterology. 55:1513–1518.
2008.PubMed/NCBI
|
|
11
|
Tomás-Loba A, Flores I, Fernández-Marcos
PJ, et al: Telomerase reverse transcriptase delays aging in
cancer-resistant mice. Cell. 135:609–622. 2008.PubMed/NCBI
|
|
12
|
González-Suárez E, Geserick C, Flores JM
and Blasco MA: Antagonistic effects of telomerase on cancer and
aging in K5-mTert transgenic mice. Oncogene. 24:2256–2270.
2005.PubMed/NCBI
|
|
13
|
Shay JW and Wright WE: Telomeres and
telomerase: implications for cancer and aging. Radiat Res.
155:188–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rudolph KL, Chang S, Lee HW, et al:
Longevity, stress response, and cancer in aging
telomerase-deficient mice. Cell. 96:701–712. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matthews P and Jones CJ: Clinical
implications of telomerase detection. Histopathology. 38:485–498.
2001. View Article : Google Scholar
|
|
16
|
Yoshida K, Sugino T, Goodison S, et al:
Detection of telomerase activity in exfoliated cancer cells in
colonic luminal washings and its related clinical implications. Br
J Cancer. 75:548–553. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chatziantoniou VD: Telomerase: biological
function and potential role in cancer management. Pathol Oncol Res.
7:161–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stewart SA and Bertuch AA: The role of
telomeres and telomerase in cancer research. Cancer Res.
70:7365–7371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hahn WC: Role of telomeres and telomerase
in the pathogenesis of human cancer. J Clin Oncol. 21:2034–2043.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldman MA: The role of telomeres and
telomerase in cancer. Drug Discov Today. 8:294–296. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Falchetti ML, Pallini R, D’Ambrosio E, et
al: In situ detection of telomerase catalytic subunit mRNA in
glioblastoma multiforme. Int J Cancer. 88:895–901. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harada K, Yasoshima M, Ozaki S, Sanzen T
and Nakanuma Y: PCR and in situ hybridization studies of telomerase
subunits in human non-neoplastic livers. J Pathol. 193:210–217.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawanishi-Tabata R, Lopez F, Fratantonio
S, et al: Telomerase activity in stage II colorectal carcinoma.
Cancer. 95:1834–1839. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang H, Kyo S, Takatura M and Sun L:
Autocrine transforming growth factor beta suppresses telomerase
activity and transcription of human telomerase reverse
transcriptase in human cancer cells. Cell Growth Differ.
12:119–127. 2001.
|
|
25
|
Engelhardt M, Drullinsky P, Guillem J and
Moore MA: Telomerase and telomere length in the development and
progression of premalignant lesions to colorectal cancer. Clin
Cancer Res. 3:1931–1941. 1997.PubMed/NCBI
|
|
26
|
Salvia R, Bassi C, Festa L, et al:
Clinical and biological behavior of pancreatic solid
pseudopapillary tumors: report on 31 consecutive patients. J Surg
Oncol. 95:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guilleret I and Benhattar J: Demethylation
of the human telomerase catalytic subunit (hTERT) gene promoter
reduced hTERT expression and telomerase activity and shortened
telomeres. Exp Cell Res. 289:326–334. 2003. View Article : Google Scholar
|
|
28
|
Wang XY, Lai ZS, Yeung CM, et al:
Establishment and characterization of a new cell line derived from
human colorectal laterally spreading tumor. World J Gastroenterol.
14:1204–1211. 2008. View Article : Google Scholar : PubMed/NCBI
|
